Cadila launches biosimilar of Adalimumab
Zydus Cadila has launched a biosimilar of Adalimumab, which is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis and Ankylosing Spondylitis.
READ MORE:
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
